NASDAQ
Defence Therapeutics Inc. (DTCFF) has a fcf yield of -7.91% as of Friday, May 29, 2026. This represents a 13.49% decrease compared to its 12-month average of -6.97%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.